Journal article 397 views
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
Zenobia C. D’Costa,
Catherine Higgins,
Chee Wee Ong,
Gareth W. Irwin,
David Boyle,
Darragh G. McArt,
Karen McCloskey,
Niamh E. Buckley,
Nyree T. Crawford,
Lalitha Thiagarajan,
James Murray 
,
Richard D. Kennedy,
Karl A. Mulligan,
D. Paul Harkin,
David J.J. Waugh,
Chris J. Scott,
Manuel Salto-Tellez,
Richard Williams,
Paul B. Mullan
,
Richard D. Kennedy,
Karl A. Mulligan,
D. Paul Harkin,
David J.J. Waugh,
Chris J. Scott,
Manuel Salto-Tellez,
Richard Williams,
Paul B. Mullan
Oncotarget, Volume: 5, Issue: 6, Pages: 1609 - 1620
Swansea University Author:
James Murray
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.18632/oncotarget.1707
Abstract
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
| Published in: | Oncotarget |
|---|---|
| ISSN: | 1949-2553 |
| Published: |
Impact Journals, LLC
2014
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa56402 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Keywords: |
TBX2, CST6, LGMN, breast cancer |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Issue: |
6 |
| Start Page: |
1609 |
| End Page: |
1620 |